HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use INFLECTRA safely and effectively. See full prescribing information for INFLECTRA.
INFLECTRA® (infliximab-dyyb) Lyophilized Concentrate for Injection, for Intravenous Use
Initial U.S. Approval: 2016
INFLECTRA (infliximab-dyyb) is biosimilar1 to REMICADE (infliximab). (1)
WARNING: SERIOUS INFECTIONS and MALIGNANCY
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.